Cardiometabolic Health Management

Inquiry

Inquiry: What if we could transform chronic disease management by integrating advanced vital sign monitoring with evidence-based digital therapeutics?

Innovation

CHAPERONE

Company:

Aventyn

Research Partner

Arizona State University and University of Arizona

Principle Investigator

Kris Vijay MD, Michael Castro MD

Research Objective:

Product Commercialization

Cohort:

4

Visit Site

M

anaging chronic conditions like cardiovascular, metabolic, and kidney diseases requires precise monitoring and actionable insights. CHAPERONE is revolutionizing care with its multi-sensor wearable device, designed to monitor vital signs such as Cardiac Output, Stroke Volume, Respiration Rate, Heart Rate Variability, and more. By delivering evidence-based digital therapeutic biomarkers, CHAPERONE empowers healthcare providers and patients to make informed decisions, improving outcomes and enhancing quality of life. This next-generation innovation bridges the gap between continuous health monitoring and proactive disease management, setting a new standard for chronic care solutions.

No items found.

Innovator's Journey:

WearTech Ecosystem

Our network of partners can help connect project teams with resources.

WATCH more

press

WearTech: One of Arizona's newest wearable tech companies

FOX10

Wearable technology initiative receives $1.6M in funding from Arizona Commerce Authority

Phoenix Business Journal

WearTech Applied Research Center and GoX Labs Unveil Made-in-Arizona Superhuman Exoskeleton

Robotics Tomorrow

Back to projects

Thank you for subscribing!
Error!